Bladder Urothelial Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2016-04-18
Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation After Cisplatin-Based Chemotherapy and Surgery in Treating Patients With High-Risk Bladder Cancer [Phase 2]
Phase 2 trial evaluating nab-paclitaxel after cisplatin-based chemotherapy and surgery for high-risk bladder cancer has been withdrawn.